Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Syndecan 4 ELISA Kit (AC3177)
Cat.#: ASET-1766
Specifications
Description Mouse Syndecan 4 ELISA Kit allows for the in vitro quantitative determination of mouse Syndecan 4 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1734 Mouse GDF11 ELISA Kit (AC3145) Quantitative inquiry ASET-1180 Human Agrin ELISA Kit (AC2591) Quantitative inquiry ASET-2179 Rat NMDAR1 ELISA Kit (AC3590) Quantitative inquiry ASET-1284 Human alpha B Crystallin ELISA Kit (AC2695) Quantitative inquiry ASET-1981 Human NRG3 ELISA Kit (AC3392) Quantitative inquiry ASET-1424 Human Semaphorin 3F ELISA Kit (AC2835) Quantitative inquiry ASET-1121 Human TBX1 ELISA Kit (AC2532) Quantitative inquiry ASET-1811 Human Substance P ELISA Kit (AC3222) Quantitative inquiry ASET-1024 Chicken FGF2 ELISA Kit (AC2435) Quantitative inquiry ASET-1492 Human GABARAPL1 ELISA Kit (AC2903) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket